12/4
11:58 pm
pfe
FDA chief claims Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]
Low
Report
FDA chief claims Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]
12/4
10:04 pm
pfe
Pfizer Inc. (PFE): A Bull Case Theory [Yahoo! Finance]
Low
Report
Pfizer Inc. (PFE): A Bull Case Theory [Yahoo! Finance]
12/4
05:58 pm
pfe
FDA chief says Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]
Low
Report
FDA chief says Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]
12/4
12:31 am
pfe
Jim Cramer on Pfizer: “I Would Hold on to It” [Yahoo! Finance]
Low
Report
Jim Cramer on Pfizer: “I Would Hold on to It” [Yahoo! Finance]
12/2
07:07 pm
pfe
Nanopharmaceuticals Research Report 2025: Market to Reach $104.58 Billion by 2030, Driven by Rising Chronic Disease Burden and Growing Investment in Regenerative Medicine and Nanotechnology Drugs [Yahoo! Finance]
Low
Report
Nanopharmaceuticals Research Report 2025: Market to Reach $104.58 Billion by 2030, Driven by Rising Chronic Disease Burden and Growing Investment in Regenerative Medicine and Nanotechnology Drugs [Yahoo! Finance]
12/2
02:43 pm
pfe
Pfizer mRNA Influenza Vaccine 'Failed' In Clinical Trial Among Seniors: FDA Commissioner [zero hedge]
Low
Report
Pfizer mRNA Influenza Vaccine 'Failed' In Clinical Trial Among Seniors: FDA Commissioner [zero hedge]
12/2
08:18 am
pfe
If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now? [Yahoo! Finance]
Low
Report
If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now? [Yahoo! Finance]
12/2
08:04 am
pfe
Pfizer (NYSE:PFE) had its "neutral" rating reaffirmed by analysts at Citigroup Inc.. They now have a $26.00 price target on the stock.
Low
Report
Pfizer (NYSE:PFE) had its "neutral" rating reaffirmed by analysts at Citigroup Inc.. They now have a $26.00 price target on the stock.
12/1
11:12 am
pfe
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance [Yahoo! Finance]
Low
Report
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance [Yahoo! Finance]
12/1
10:47 am
pfe
Tattoo ink moves through the body, killing immune cells and weakening vaccine response [Los Angeles Times (CA)]
Low
Report
Tattoo ink moves through the body, killing immune cells and weakening vaccine response [Los Angeles Times (CA)]
12/1
10:00 am
pfe
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
Low
Report
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
11/29
07:23 pm
pfe
With 66% institutional ownership, Pfizer Inc. (NYSE:PFE) is a favorite amongst the big guns [Yahoo! Finance]
Low
Report
With 66% institutional ownership, Pfizer Inc. (NYSE:PFE) is a favorite amongst the big guns [Yahoo! Finance]
11/29
01:58 pm
pfe
FDA claims Covid shots killed 10 children and vows new vaccine rules [MSNBC.com]
Low
Report
FDA claims Covid shots killed 10 children and vows new vaccine rules [MSNBC.com]
11/28
08:33 am
pfe
$92.91 Bn Nasal Drug Delivery Market Trends, Opportunities, and Forecasts, 2020-2024 & 2025-2030F [Yahoo! Finance]
Low
Report
$92.91 Bn Nasal Drug Delivery Market Trends, Opportunities, and Forecasts, 2020-2024 & 2025-2030F [Yahoo! Finance]
11/28
02:42 am
pfe
Guggenheim Lifts PT on Pfizer Inc. (PFE) to $35 From $33, Keeps a Buy Rating [Yahoo! Finance]
Low
Report
Guggenheim Lifts PT on Pfizer Inc. (PFE) to $35 From $33, Keeps a Buy Rating [Yahoo! Finance]
11/27
12:04 am
pfe
Why it's time to speed up access to life-changing cancer therapies [Globe and Mail, The (Toronto, Canada)]
Low
Report
Why it's time to speed up access to life-changing cancer therapies [Globe and Mail, The (Toronto, Canada)]
11/24
08:43 am
pfe
Pfizer (NYSE:PFE) had its price target raised by analysts at Guggenheim from $33.00 to $35.00. They now have a "buy" rating on the stock.
Low
Report
Pfizer (NYSE:PFE) had its price target raised by analysts at Guggenheim from $33.00 to $35.00. They now have a "buy" rating on the stock.
11/22
08:07 am
pfe
Long COVID's Shadow Lingers [Forbes]
Low
Report
Long COVID's Shadow Lingers [Forbes]
11/21
01:24 pm
pfe
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
Low
Report
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
11/20
07:24 am
pfe
Moderna takes $1.5 billion loan, expects 10% revenue growth next year [Yahoo! Finance Canada]
Low
Report
Moderna takes $1.5 billion loan, expects 10% revenue growth next year [Yahoo! Finance Canada]
11/19
06:25 pm
pfe
Pfizer, Tris Pharma Settle For $41.5 Mn In Texas ADHD Drug Case [Barron's]
Low
Report
Pfizer, Tris Pharma Settle For $41.5 Mn In Texas ADHD Drug Case [Barron's]
11/19
05:58 pm
pfe
Pfizer's mRNA flu shot outperforms standard flu vaccine in late-stage trial [MSNBC.com]
Low
Report
Pfizer's mRNA flu shot outperforms standard flu vaccine in late-stage trial [MSNBC.com]
11/19
09:28 am
pfe
Safeguard Global Maps Hotspots to Find Pharma Talent in Inaugural Industry Intelligence Report [Yahoo! Finance]
Low
Report
Safeguard Global Maps Hotspots to Find Pharma Talent in Inaugural Industry Intelligence Report [Yahoo! Finance]
11/19
09:02 am
pfe
Moderna to complete US mRNA manufacturing network with $140 million investment [Yahoo! Finance]
Low
Report
Moderna to complete US mRNA manufacturing network with $140 million investment [Yahoo! Finance]
11/19
07:38 am
pfe
Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery [Yahoo! Finance]
Low
Report
Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery [Yahoo! Finance]